首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: Curcumin therapeutic potential
【24h】

In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: Curcumin therapeutic potential

机译:壳聚糖/藻酸盐/麦芽糖糊精/ Pluronic系混合聚合物胶束的体内抗糖尿病和伤口愈合潜力:姜黄素治疗潜力

获取原文
获取原文并翻译 | 示例
       

摘要

Development of curcumin-loaded mixed polymeric micelles based on chitosan, alginate, maltodextrin, pluronic F127, pluronic P123, and tween 80, by thin-film hydration method has been investigated in Bisphenol A induced diabetics rats. Curcumin (C21H20O6) extracted from rhizomes of the "Curcuma longa" has attracted considerable attention of pharmaceutical researchers due to its low cost, excellent pharmacological activities and lesser side effects. Despite its diverse pharmacological properties, the therapeutic application of curcumin as an oral therapy has been limited due to its poor aqueous solubility, fixed chemical stability, and low bioavailability. In an attempt to overcome these limitations, we developed curcumin-loaded mixed polymeric micelles. Diabetes mellitus is a most common chronic carbohydrate metabolic disorder. The results clearly demonstrated the ability of developed formulation to reduce the elevated blood glucose level and lipid profile (total cholesterol, triglycerides). It maintained the body-weight, HDL cholesterol level, various biochemical parameters and accelerated the wound healing process when treated with these curcumin-based formulations. The treatment of curcumin loaded mixed polymeric formulations allowed a favorable inhibitory effect to these histopathological changes of liver, kidney, and pancreas. The newly developed curcumin-based formulations have proved superior therapeutic potential and excellent healing efficacy as compared to standard drugs and pure curcumin. (C) 2018 Elsevier B.V. All rights reserved .
机译:在双酚A诱导的糖尿病患者大鼠中研究了基于壳聚糖,藻酸盐,麦芽糖糊精,Pluronic F127,Pluronic P123和Tween 80的姜黄素加载的混合聚合物胶束。由于其低成本,优异的药理学活动和较小的副作用,从“Curcuma Longa”的根茎中提取的姜黄素(C21H20O6)引起了药物研究人员的大幅关注。尽管其不同的药理性质,因此由于其差的水溶性,固定化学稳定性和低生物利用度,姜黄素作为口服治疗的治疗施用。为了克服这些限制,我们开发了姜黄素加载的混合聚合物胶束。糖尿病是一种最常见的慢性碳水化合物代谢紊乱。结果清楚地证明了开发的配方减少血糖水平和脂质曲线(总胆固醇,甘油三酯)的能力。当用这些姜黄素的配方处理时,它保持体重,HDL胆固醇水平,各种生化参数,加速伤口愈合过程。姜黄素负载混合聚合物制剂的处理允许对肝,肾和胰腺的这些组织病理学变化具有良好的抑制作用。与标准药物和纯姜黄素相比,新开发的姜黄素的配方已经证明了优异的治疗潜力和优异的愈合效果。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号